Saturday 17 October 2026
Export TCMD’s income statement to Excel — free account
Tactile Systems Technology, Inc.
TCMD Healthcare Medical Devices
Tactile Systems Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $329.5 million, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 8.61%, EPS grew 142.9% and free cash flow fell 86.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
22.52
0.77
−3.31%
Follow TCMD
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
27.07 | 29.03 | 34.12 | 17.74 |
+8 more quarters Free account |
P/S ratio |
1.93 | 1.72 | 2.01 | 0.99 | |
P/FCF ratio |
25.32 | 15.08 | 16.47 | 7.84 | |
P/Operating CF |
207.54 | (1,739.00) | 38.35 | 29.87 | |
P/B ratio |
3.02 | 2.71 | 3.03 | 1.51 | |
Price to Tangible BV |
4.84 | 4.33 | 4.46 | 2.31 | |
EV/Sales |
1.75 | 1.52 | 1.78 | 0.80 | |
EV/EBITDA |
14.67 | 13.41 | 16.31 | 8.40 | |
EV/Operating CF |
20.04 | 12.39 | 13.68 | 5.97 | |
EV/FCF |
22.96 | 13.33 | 14.55 | 6.34 | |
Quick Ratio |
3.37 | 3.57 | 3.49 | 3.01 | |
Current Ratio |
4.12 | 4.24 | 4.03 | 3.61 | |
Net Debt/EBITDA |
(9.82) | (858.96) | (4.86) | (6.41) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.27 | 1.24 | 1.15 | 1.14 | |
Operating CF/Net income |
0.42 | 0.19 | 1.63 | 1.26 | |
Capex/Depreciation |
(0.73) | (0.51) | (0.36) | (0.70) | |
Interest Coverage |
359.26 | (54.79) | 1,706.82 | 56.80 | |
Research and Development Expense of Revenue |
2.92% | 3.69% | 2.44% | 2.55% | |
Selling, General and Administrative Expense of Revenue |
64.61% | 74.10% | 57.05% | 59.76% | |
Intangible Assets out of Total Assets |
0.30 | 0.30 | 0.26 | 0.27 | |
Share Based Compensation of Revenue |
2.64% | 2.36% | 2.45% | 2.12% | |
Graham Net Nets |
0.15 | 0.17 | 0.17 | 0.28 | |
Graham Number |
15.63 | 13.98 | 13.53 | 12.69 | |
Earnings Yield |
3.69% | 3.44% | 2.93% | 5.64% | |
Free Cash Flow Yield |
3.95% | 6.63% | 6.07% | 12.75% | |
Revenue per Share |
3.78 | 3.34 | 4.53 | 3.84 | |
Operating CF per Share |
0.14 | (0.01) | 0.76 | 0.46 | |
Capex per Share |
(0.06) | (0.04) | (0.03) | (0.05) | |
Free Cash Flow per Share |
0.09 | (0.05) | 0.73 | 0.41 | |
Cash per Share |
3.74 | 4.00 | 4.34 | 3.62 | |
Shareholders Equity per Share |
9.87 | 9.66 | 9.57 | 9.18 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
9.87 | 9.66 | 9.57 | 9.18 | |
Free Cash Flow |
1.94 | (1.17) | 16.72 | 9.19 | |
Working Capital |
119.35 | 116.83 | 124.21 | 102.21 | |
Capital Expenditures |
(1.32) | (0.83) | (0.58) | (1.15) | |
Net Current Asset Value |
101.77 | 98.59 | 110.13 | 87.17 | |
EV/EBIT |
17.48 | 16.14 | 20.01 | 10.85 | |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
19.28 | 18.26 | 22.66 | 13.42 | |
| Other line items | |||||
Average Receivables |
38.80 | 37.55 | 44.41 | 38.61 | |
Average Payables |
7.97 | 7.17 | 5.31 | 7.64 | |
Average Inventory |
16.98 | 17.72 | 16.35 | 18.63 | |
Average Assets |
276.36 | 276.18 | 285.93 | 273.45 | |
Average Common Equity |
209.38 | 211.75 | 217.75 | 206.43 |
Columns are period end dates